Swiss startup betting on nanotechnology to speed cancer diagnosis October 27, 2020 Auto Bot Basel, BioPharma, biopharma nl, Diagnostics, Medical Devices, News, Switzerland 0 Founded in 2017, Artidis has raised $15.1 million and hopes to enter the U.S. market for cancer diagnosis by 2022. But the startup first has to convince the FDA that its device works.